Evidence map›Paper›PMID 33526826›Full record

ArticleScientific reports2021

Regenerative tissue filler for breast conserving surgery and other soft tissue restoration and reconstruction needs.

Theodore J Puls, Carla S Fisher, Abigail Cox, Jeannie M Plantenga, Emma L McBride, Jennifer L Anderson, Craig J Goergen, Melissa Bible, Tracy Moller, Sherry L Voytik-Harbin

Abstract read
In one paragraph

Article in Scientific reports, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Advanced Hydrogels in Breast Cancer Therapy.Gels (Basel, Switzerland) · 2024
    Review
  11. Review
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Theodore J PulsGeniPhys, LLC, Zionsville, IN, 46077, USA.
Carla S FisherDivision of Surgery, Indiana University School of Medicine, Indianapolis, IN, 46202, USA.
Abigail CoxDepartment of Comparative Pathobiology, College of Veterinary Medicine, Purdue University, West Lafayette, IN, 47907, USA.
Jeannie M PlantengaDepartment of Veterinary Clinical Sciences, College of Veterinary Medicine, Purdue University, West Lafayette, IN, 47907, USA.
Emma L McBrideWeldon School of Biomedical Engineering, College of Engineering, Purdue University, West Lafayette, IN, 47907, USA.
Jennifer L AndersonWeldon School of Biomedical Engineering, College of Engineering, Purdue University, West Lafayette, IN, 47907, USA.
Craig J GoergenWeldon School of Biomedical Engineering, College of Engineering, Purdue University, West Lafayette, IN, 47907, USA.
Melissa BibleWeldon School of Biomedical Engineering, College of Engineering, Purdue University, West Lafayette, IN, 47907, USA.
Tracy MollerWeldon School of Biomedical Engineering, College of Engineering, Purdue University, West Lafayette, IN, 47907, USA.
Sherry L Voytik-HarbinWeldon School of Biomedical Engineering, College of Engineering, Purdue University, West Lafayette, IN, 47907, USA. harbins@purdue.edu.

Funding

Indiana Medical Scientist/Engineer Training ProgramT32GM077229 · NIGMS · INDIANA UNIVERSITY INDIANAPOLIS · PI GASTON, BENJAMIN, HERBERT, BRITTNEY-SHEA · 2008 to 2022
$6.0M
Interdisciplinary Bioengineering Training in Diabetes ResearchT32DK101001 · NIDDK · PURDUE UNIVERSITY · PI EVANS-MOLINA, CARMELLA, VOYTIK-HARBIN, SHERRY L · 2013 to 2022
$1.6M
Long-term non-enzymatic glucose sensor for an artificial pancreasR44DK101000 · NIDDK · PROFUSA, INC. · PI WISNIEWSKI, NATALIE ANN · 2016 to 2017
$1.5M
Late stage development and preparation of a long-term non-enzymatic continuous glucose sensor for clinical trialsSB1DK101000 · NIDDK · PROFUSA, INC. · PI GAMSEY, SOYA, REBRIN, KERSTIN · 2018 to 2019
$962k
Long-Term Non-Enzymatic Glucose Sensors for an Artificial PancreasR43DK101000 · NIDDK · PROFUSA, INC. · PI WISNIEWSKI, NATALIE ANN · 2013 to 2014
$252k
NIDDK NIH HHS R43 DK101000NIDDK NIH HHS R44 DK101000NIDDK NIH HHS SB1 DK101000NIDDK NIH HHS T32 DK101001NIGMS NIH HHS T32 GM077229
6 · The paper itself

Abstract

Complete removal of cancerous tissue and preservation of breast cosmesis with a single breast conserving surgery (BCS) is essential for surgeons. New and better options would allow them to more consistently achieve this goal and expand the number of women that receive this preferred therapy, while minimizing the need for re-excision and revision procedures or more aggressive surgical approaches (i.e., mastectomy). We have developed and evaluated a regenerative tissue filler that is applied as a liquid to defects during BCS prior to transitioning to a fibrillar collagen scaffold with soft tissue consistency. Using a porcine simulated BCS model, the collagen filler was shown to induce a regenerative healing response, characterized by rapid cellularization, vascularization, and progressive breast tissue neogenesis, including adipose tissue and mammary glands and ducts. Unlike conventional biomaterials, no foreign body response or inflammatory-mediated "active" biodegradation was observed. The collagen filler also did not compromise simulated surgical re-excision, radiography, or ultrasonography procedures, features that are important for clinical translation. When post-BCS radiation was applied, the collagen filler and its associated tissue response were largely similar to non-irradiated conditions; however, as expected, healing was modestly slower. This in situ scaffold-forming collagen is easy to apply, conforms to patient-specific defects, and regenerates complex soft tissues in the absence of inflammation. It has significant translational potential as the first regenerative tissue filler for BCS as well as other soft tissue restoration and reconstruction needs.

Indexed as

AnimalsBreast NeoplasmsCarcinoma, Ductal, BreastFemaleHumansMammary Glands, HumanMastectomyMastectomy, SegmentalPlastic Surgery ProceduresSwineTissue Scaffolds

Identifiers

PMID33526826
PMCPMC7851166

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.